Mepartricin

Mepartricin
Systematic (IUPAC) name

(19E,21E,23Z,25Z,27E,29E,31E)-methyl 34-((2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-1,3,5,7,9,13,37-heptahydroxy-17-(5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl)-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate
Clinical data
AHFS/Drugs.com	International Drug Names
Identifiers
CAS Registry Number	62534-68-3^Y
ATC code	A01AB16 D01AA06 G01AA09 G04CX03
PubChem	CID 6479653
ChemSpider	21106342^Y
ChEMBL	CHEMBL2106426
Chemical data
Formula	C₆₀H₈₈N₂O₁₉
Molecular mass	1141.34 g/mol
SMILES CNc1ccc(cc1)C(=O)CC(O)CCC(C)C3OC(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC4(O)CC(O)C(C(=O)OC)C(CC(O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)/C=C/C=C/C=C/C=C\C=C/C=C/C=C/C3C)O4
InChI InChI=1S/C60H88N2O19/c1-36-18-16-14-12-10-8-6-7-9-11-13-15-17-19-48(79-59-56(74)54(61)55(73)38(3)78-59)33-51-53(58(75)77-5)50(71)35-60(76,81-51)34-47(69)30-45(67)28-43(65)26-42(64)27-44(66)29-46(68)32-52(72)80-57(36)37(2)20-25-41(63)31-49(70)39-21-23-40(62-4)24-22-39/h6-19,21-24,36-38,41-43,45-48,50-51,53-57,59,62-65,67-69,71,73-74,76H,20,25-35,61H2,1-5H3/b7-6-,10-8-,11-9+,14-12+,15-13+,18-16+,19-17+/t36?,37?,38-,41?,42?,43?,45?,46?,47?,48?,50?,51?,53?,54+,55-,56+,57?,59+,60?/m1/s1 ^Y Key:GVEVTKSEPQUIJA-PLDHRHJXSA-N ^Y
Y (what is this?) (verify)

Mepartricin is an antibiotic. It has been studied for use in treating chronic pelvic pain syndrome.^[1]^[2]

References

↑ De Rose AF, Gallo F, Giglio M, Carmignani G (January 2004). "Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial". Urology 63 (1): 13–6. doi:10.1016/j.urology.2003.08.006. PMID 14751338.
↑ Erickson BA, Schaeffer AJ, Van Le B (2008). "Chronic prostatitis". Clin Evid (Online) 2008. PMC 2907954. PMID 19450305.

Stomatological preparations (A01)

Caries
prophylactic
agents

Anti-infectives
and antiseptics

Corticosteroids
(Glucocorticoids)

Other

Index of the mouth

Description	Anatomy Development

Disease	Congenital face and neck cleft digestive system Neoplasms and cancer Other Symptoms and signs

Treatment	Procedures periodontology Drugs

Drugs used in benign prostatic hyperplasia (G04C)

5α-reductase inhibitors

Alpha blockers (α₁)

Other

Mepartricin

Index of reproductive medicine

Description	Anatomy male female Physiology menstrual cycle Development sex determination and differentiation

Disease	Infections STD and STI Congenital male female Neoplasms and cancer male female gonadal germ cell Other male female Symptoms and signs eponymous

Treatment	Procedures male female Drugs benign prostatic hypertrophy erectile dysfunction and premature ejaculation sexual dysfunction infection STDs hormones androgens estrogens progestogens GnRH prolactin Assisted reproduction Birth control hormonal